Dental and Medical Problems

Dent Med Probl
Index Copernicus (ICV 2021) – 132.50
MEiN – 70 pts
CiteScore (2021) – 2.0
JCI (2021) – 0.5
Average rejection rate (2022) – 79.69%
ISSN 1644-387X (print)
ISSN 2300-9020 (online)
Periodicity – quarterly

Download PDF

Dental and Medical Problems

2013, vol. 50, nr 2, April-June, p. 145–151

Publication type: editorial article

Language: English

A New Approach for Genetic Factors Influencing Periodontitis

Nowości dotyczące czynników genetycznych zapalenia przyzębia

Grzegorz Szparecki1,A,D,E, Martyna Czerkies2,B,E, Andrzej Miskiewicz3,B,D,E

1 Department of Pathology, Medical University of Warsaw, Poland

2 Department of Orthodontics, Medical University of Warsaw, Poland

3 Department of Periodontology, Medical University of Warsaw, Poland


Periodontitis is a variety of conditions which affect the tissues surrounding the tooth. The pathological process results from a distortion of balance between dental plaque bacteria and immunological system of the host. Moreover, the onset and the course of periodontitis are modulated by the impact of genetic mechanisms mutually with risk factors. Genetic influence on the periodontitis might be divided into the following groups: single nucleotide polymorphisms: Il-1β and CD14 receptor; inherited immunodeficiencies: benign familial neutropenia, leukocyte adhesion deficiency, Chediak-Higashi syndrome, Kostmann disease; connective tissues disorders: keratoderma, Ehlers-Danlos syndrome, hypophosphatasia, Marfan syndrome and familial immunodeficiencies.


Zapalenie przyzębia jest dużą grupą schorzeń tkanek podtrzymujących ząb. Proces patologiczny wynika z zaburzenia stanu dynamicznej równowagi między bakteriami zasiedlającymi płytkę nazębną a układem immunologicznym gospodarza. Ponadto początek oraz przebieg zapalenia przyzębia jest modulowany przez wpływ współwystępujących czynników ryzyka oraz wiele mechanizmów genetycznych. Wpływ czynników genetycznych na etiopatogenezę zapalenia klasyfikuje się następująco: polimorfizm pojedynczych nukloetydów: IL -1β oraz receptora CD14; wrodzone niedobory odporności: rodzinna neutropenia, zespół zaburzonej adhezji leukocytów, zespół Chediaka-Higashiego, choroba Kostmanna; zaburzenia tkanki łącznej: keratoderma, zespół Ehlersa-Danlosa, hipofosfatazja, zespół Marfana oraz dziedziczne zespoły zaburzonej odporności.

Key words

single nucleotide polymorphisms, benign familial neutropenia, leukocyte adhesion deficiency, Down syndrome

Słowa kluczowe

polimorfizm pojedynczych nukleotydów, rodzinna neutropenia, zespół zaburzonej adhezji leukocytów, zespół Downa

References (61)

  1. Agrawal P., Sanikop S., Patil S.: New developments in tools for periodontal diagnosis. Int. Dent. J. 2012, 62, 57–64.
  2. Sreedevi M., Ramesh A., Dwarakanath C.: Periodontal status in smokers and nonsmokers: a clinical, microbiological, and histopathological study. Int. J. Dent. 2012, 571–590.
  3. Arslan S.G., Akpolat N., Kama J.D., Ozer T., Hamamci O.: One-year follow-up of the effect of fixed orthodontic treatment on colonization by oral Candida. J. Oral Pathol. Med. 2008, 37, 26–29.
  4. Miskiewicz A., Szparecki G.: Periodontitis as a R isk Factor in Cardiovascular Diseases. Dent. Med. Probl. 2010, 47, 472–477.
  5. Miskiewicz A., Szparecki G.: Salivary markers and periodontal symptoms in pancreatic cancer. Gastroeneterol. Pol. 2011, 18, 115–119.
  6. Socransky S.S., Haffajee A.D., Cugini M.A., Smith C., Kent R.L. Jr.: Microbial complexes in subgingival plaque. J. Clin. Periodontol. 1998, 25, 134–144.
  7. Kukita A., Ichigi Y., Takigawa I., Watanabe T., Kukita T., Miyamoto H.: Infection of RANKL-Primed RAW-D Macrophages with Porphyromonas gingivalis Promotes Osteoclastogenesis in a T NF-alpha-Independent Manner. PLoS One. 2012, 7, e38500.
  8. Ghizoni J.S., Taveira L.A., Garlet G.P., Ghizoni M.F., Pereira J.R., Dionisio T.J. et al.: Increased levels of Porphyromonas gingivalis are associated with ischemic and hemorrhagic cerebrovascular disease in humans: an in vivo study. J. Appl. Oral Sci. 2012, 20, 104–112.
  9. Nicu E.A., Laine M.L., Morre S.A., Van der Velden U., Loos B.G.: Soluble CD14 in periodontitis. Innate Immun. 2009, 15, 121–128.
  10. Holla L.I., Buckova D., Fassmann A., Halabala T., Vasku A., Vacha J.: Promoter polymorphisms in the CD14 receptor gene and their potential association with the severity of chronic periodontitis. J. Med. Genet. 2002, 39, 844–848.
  11. Belibasakis G.N., Johansson A.: Aggregatibacter actinomycetemcomitans targets NLRP3 and NLRP6 inflammasome expression in human mononuclear leukocytes. Cytokine 2012, 59, 124–130.
  12. Martinon F., Burns K., Tschopp J.: The inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of proIL-beta. Mol. Cell. 2002, 10, 417–426.
  13. Petrilli V., Papin S., Dostert C., Mayor A., Martinon F., Tschopp J.: Activation of the NALP3 inflammasome is triggered by low intracellular potassium concentration. Cell Death Differ. 2007, 14, 1583–1589.
  14. Amano A., Inaba H.: Cardiovascular diseases and periodontal diseases. Clin. Calcium. 2012, 22, 43–48.
  15. Montebugnoli L., Servidio D., Miaton R.A., Prati C., Tricoci P., Melloni C. et al.: Periodontal health improves systemic inflammatory and haemostatic status in subjects with coronary heart disease. J. Clin. Periodontol. 2005, 32, 188–192.
  16. Wisniewska-Spychala B., Sokalski J., Grajek S., Jemielity M., Trojnarska O., Choroszy-Krol I. et al.: Dentigenous infectious foci – a risk factor of infective endocarditis. Med. Sci. Monit. 2012, 18, CR93–104.
  17. El-Awady A.R., Lapp C.A., Gamal A.Y., Sharawy M.M., Wenger K.H., Cutler C.W. et al.: Human periodontal ligament fibroblast responses to compression in chronic periodontitis. J. Clin. Periodontol. 2013, 23.
  18. Genco R.J., Borgnakke W.S.: Risk factors for periodontal disease. Periodontology 2000, 62, 59–94.
  19. Schaefer A.S., Bochenek G., Manke T., Nothnagel M., Graetz C., Thien A. et al.: Validation of reported genetic risk factors for periodontitis in a large-scale replication study. J. Clin. Periodontol. 2013, 4.
  20. Van Dyke T.E.: The impact of genotypes and immune reactivity on peri-implant inflammation: Identification and therapeutic use of anti-inflammatory drugs and immunomodulators. Eur. J. Oral Implantol. 2012, Suppl. S51–60.
  21. Bernini J.C.: Diagnosis and management of chronic neutropenia during childhood. Pediatr. Clin. North Am. 1996, 43, 773–792.
  22. Stabholz A., Soskolne V., Machtei E., Or R., Soskolne W.A.: Effect of benign familial neutropenia on the periodontium of Yemenite Jews. J. Periodontol. 1990, 61, 51–54.
  23. Casey C., Brooke T., Davies R., Franklin D.: Case report of a family with benign familial neutropenia and the implications for the general dental practitioner. Dent. Update 2011, 38, 106–110.
  24. Van Vliet D.N., Brandsma A.E., Hartwig N.G.: Leukocyte-adhesion deficiency: a rare disorder of inflammation. Ned. Tijdschr. Geneeskd. 2004, 148, 2496–2500.
  25. Toomarian L., Hashemi N.: Periodontal manifestation of leukocyte adhesion deficiency type I. Arch. Iran Med. 2010, 13, 355–359.
  26. Stovall T.G., Ling F.W.: Splenosis: report of a case and review of the literature. Obstet. Gynecol. Surv. 1988, 43, 69–72.
  27. Bailleul-Forestier I., Monod-Broca J., Benkerrou M., Mora F., Picard B.: Generalized periodontitis associated with Chediak-Higashi syndrome. J. Periodontol. 2008, 79, 1263–1270.
  28. Shibutani T., Gen K., Shibata M., Horiguchi Y., Kondo N., Iwayama Y.: Long-term follow-up of periodontitis in a patient with Chediak-Higashi syndrome. A case report. J. Periodontol. 2000, 71, 1024–1028.
  29. Antonio A.G., Alcantara P.C., Ramos M.E., de Souza I.P.: The importance of dental care for a child with severe congenital neutropenia: a case report. Spec. Care Dentist. 2010, 30, 261–265.
  30. Carlsson G., Wahlin Y.B., Johansson A., Olsson A., Eriksson T., Claesson R. et al.: Periodontal disease in patients from the original Kostmann family with severe congenital neutropenia. J. Periodontol. 2006, 77, 744–751.
  31. Putsep K., Carlsson G., Boman H.G., Andersson M.: Deficiency of antibacterial peptides in patients with morbus Kostmann: an observation study. Lancet 2002, 360, 1144–1149.
  32. Pallos D., Acevedo A.C., Mestrinho H.D., Cordeiro I., Hart T.C.: Novel cathepsin C mutation in a Brazilian family with Papillon-Lefevre syndrome: case report and mutation update. J. Dent. Child (Chic). 2010, 77, 36–41.
  33. Dhanrajani P.J.: Papillon-Lefevre syndrome: clinical presentation and a brief review. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod. 2009, 108, e1–7.
  34. Reinstein E., Wang R.Y., Zhan L., Rimoin D.L., Wilcox W.R.: Ehlers-Danlos type VIII, periodontitis-type: further delineation of the syndrome in a four-generation pedigree. Am. J. Med. Genet. A 2011, 155, 742–747.
  35. Reinstein E., DeLozier C.D., Simon Z., Bannykh S., Rimoin D.L., Curry C.J.: Ehlers-Danlos syndrome type VIII is clinically heterogeneous disorder associated primarily with periodontal disease, and variable connective tissue features. Eur. J. Hum. Genet. 2013, 21, 233–236.
  36. Pierro V.S., Vazquez-Sullca R., Vieira A.S., Takiya C.M., Carakushansky G., Feres-Filho E.J.: Ligneous periodontitis and Ehlers-Danlos syndrome. J. Periodontol. 2006, 77, 123–128.
  37. Watanabe H., Goseki-Sone M., Iimura T., Oida S., Orimo H., Ishikawa I.: Molecular diagnosis of hypophosphatasia with severe periodontitis. J. Periodontol. 1999, 70, 688–691.
  38. Takinami H., Goseki-Sone M., Watanabe H., Orimo H. Hamatani R., Fukushi-Irie M. et al.: The mutant (F310L and V365I) tissue-nonspecific alkaline phosphatase gene from hypophosphatasia. J. Med. Dent. Sci. 2004, 51, 67–74.
  39. Straub A.M., Grahame R., Scully C., Tonetti M.S.: Severe periodontitis in Marfan’s syndrome: a case report. J. Periodontol. 2002, 73, 823–826.
  40. Amaral Loureiro A.C., Oliveira Costa F., Eustaquio da Costa J.: The impact of periodontal disease on the quality of life of individuals with Down syndrome. Downs Syndr. Res. Pract. 2007, 12, 50–54.
  41. Khocht A., Russell B., Cannon J.G., Turner B., Janal M.: Oxidative burst intensity of peripheral phagocytic cells and periodontitis in Down syndrome. J. Periodontal. Res. 2013, 14.
  42. Tanaka M.H., Giro E.M., Cavalcante L.B., Pires J.R., Apponi L.H., Valentini S.R. et al.: Expression of interferongamma, interferon-alpha and related genes in individuals with Down syndrome and periodontitis. Cytokine 2012, 60, 875–881.
  43. Yamazaki-Kubota T., Miyamoto M., Sano Y., Kusumoto M., Yonezu T., Sugita K. et al.: Analysis of matrix metalloproteinase (MMP-8 and MMP-2) activity in gingival crevicular fluid from children with Down’s syndrome. J. Periodontal. Res. 2010, 45, 170–176.
  44. Khocht A., Yaskell T., Janal M., Turner B.F., Rams T.E., Haffajee A.D. et al.: Subgingival microbiota in adult Down syndrome periodontitis. J. Periodontal. Res. 2012, 47, 500–507.
  45. Liu C., Hart R.P., Liu X.J., Clevenger W., Maki R.A., De Souza E.B.: Cloning and characterization of an alternatively processed human type II interleukin-1 receptor mRNA. J. Biol. Chem. 1996, 271, 20965–20972.
  46. Khocht A., Heaney K., Janal M., Turner B.: Association of interleukin-1 polymorphisms with periodontitis in Down syndrome. J. Oral Sci. 2011, 53, 193–202.
  47. Kornman K.S., Crane A., Wang H.Y., di Giovine F.S., Newman M.G., Pirk F.W. et al.: The interleukin-1 genotype as a severity factor in adult periodontal disease. J. Clin. Periodontol. 1997, 24, 72–77.
  48. Amaya M.P., Criado L., Blanco B., Gomez M., Torres O., Florez L. et al.: Polymorphisms of pro-inflammatory cytokine genes and the risk for acute suppurative or chronic nonsuppurative apical periodontitis in a Colombian population. Int. Endod. J. 2012, 12.
  49. Garlet G.P., Trombone A.P., Menezes R., Letra A., Repeke C.E., Vieira A.E. et al.: The use of chronic gingivitis as reference status increases the power and odds of periodontitis genetic studies: a proposal based in the exposure concept and clearer resistance and susceptibility phenotypes definition. J. Clin. Periodontol. 2012, 39, 323–332.
  50. Trevilatto P.C., de Souza Pardo A.P., Scarel-Caminaga R.M., de Brito R.B. Jr., Alvim-Pereira F. AlvimPereira C.C. et al.: Association of IL1 gene polymorphisms with chronic periodontitis in Brazilians. Arch. Oral Biol. 2011, 56, 54–62.
  51. Tsarev V.N., Nikolaeva E.N.: Polymorphism of IL1alpha and IL1beta genes and bacterial invasion in patients with chronic generalized periodontitis. Stomatologiia (Mosk.) 2010, 89, 19–23.
  52. Guzeldemir E., Gunhan M., Ozcelik O., Tastan H.: Interleukin-1 and tumor necrosis factor-alpha gene polymorphisms in Turkish patients with localized aggressive periodontitis. J. Oral Sci. 2008, 50, 151–159.
  53. Schulz S., Stein J.M., Altermann W., Klapproth J., Zimmermann U., Reichert Y. et al.: Single nucleotide polymorphisms in interleukin-1 gene cluster and subgingival colonization with Aggregatibacter actinomycetemcomitans in patients with aggressive periodontitis. Hum. Immunol. 2011, 72, 940–946.
  54. Setoguchi M., Nasu N., Yoshida S., Higuchi Y., Akizuki S., Yamamoto S.: Mouse and human CD14 (myeloid cell-specific leucine-rich glycoprotein) primary structure deduced from cDNA clones. Biochim. Biophys. Acta. 1989, 7, 1008, 213–222.
  55. Xu Z., Qian G.S., Li Q., Feng Q.J., Wu G.M., Li K.L.: Screening of mimetic peptides for CD14 binding site with LBP and antiendotoxin activity of mimetic peptide in vivo and in vitro. Inflamm. Res. 2009, 58, 45–53.
  56. Kirkland T.N., Viriyakosol S.: Structure-function analysis of soluble and membrane-bound CD14. Prog. Clin. Biol. Res. 1998, 397, 79–87.
  57. De Sa A.R., Moreira P.R., Xavier G.M., Sampaio I., Kalapothakis E., Dutra W.O. et al.: Association of CD14, IL1B, IL6, IL10 and TNFA functional gene polymorphisms with symptomatic dental abscesses. Int. Endod. J. 2007, 40, 563–572.
  58. Vercelli D., Baldini M., Martinez F.: The monocyte/IgE connection: may polymorphisms in the CD14 gene teach us about IgE regulation? Int. Arch. Allergy Immunol. 2001, 124, 20–24.
  59. Heesen M., Bloemeke B., Bachmann-Mennenga B., Kunz D.: The CD14-260 C --> T promoter polymorphism co-segregates with the tumor necrosis factor-alpha (TNF-alpha)-308 G --> A polymorphism and is associated with the interleukin-1 beta (IL-1 beta) synthesis capacity of human leukocytes. Eur. Cytokine Netw. 2002, 13, 230–233.
  60. Zhao L., Bracken M.B.: Association of CD14 –260 (–159) C>T and asthma: a systematic review and meta-analysis. BMC Med. Genet. 2011, 12, 93.
  61. Folwaczny M., Glas J., Torok H.P., Limbersky O., Folwaczny C.: Toll-like receptor (TLR) 2 and 4 mutations in periodontal disease. Clin. Exp. Immunol. 2004, 135, 330–335.